All In Biotech

Drug Trial Radar · NCT00797953

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

A Phase II, Double Blind, Placebo-controlled, Randominzed, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of T89 in Patient With Chronic Stable Angina Pectoris

Last checked: Nov 19, 2026Latest source record: Dec 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 124 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

124

Actual

Start

Feb 2007

Primary completion

Dec 2009

Study completion Jan 2010

Sponsor

Lead sponsor
Tasly Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Nov 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the anti-angina effect and dose response of T89, a 2-herb botanical drug product, in patients with chronic stable angina pectoris in the United States.

Conditions

  • Angina Pectoris

Interventions

  • T89Drug

    A two-herb botanical drug product in 62.5mg capsule formulation. It is to be used as 125mg or 187.5mg twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Exercise Duration (TED) change from screen baseline value in Exercise Tolerance Test (ETT) on Standard Bruce Protocol at trough drug levels at the end of the 4th and 8th week of treatment compared to placebo.Time frame: 12 weeks

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Paradigm Clinical, Inc.

    Tucson, Arizona

  • Robert M. Karns, A Medical Corporation

    Beverly Hills, California

  • Inland Heart Doctors

    Corona, California

  • Sunrise Medical Research

    Lauderdale Lakes, Florida

  • Cardiovascular Research Center of South Florida

    Miami, Florida

  • Alexandria Cardiology Clinic

    Alexandria, Louisiana

  • Great Lakes Research Group, Inc

    Bay City, Michigan

  • Marc Kozinn Associates

    Williamsville, New York

  • Oklahoma Cardiovascular & Hypertension

    Oklahoma City, Oklahoma

  • Three Rivers Medical Associates

    Columbia, South Carolina

  • East Texas Cardiology

    Houston, Texas

  • Northwest Houston Cardiology

    Houston, Texas

  • Northwest Heart Center

    Tomball, Texas

  • National Clinical Research-Norfolk, Inc

    Norfolk, Virginia

  • Gemini Scientific, LLC

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.